PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

Br J Cancer. 2015 Dec 1;113(11):1641. doi: 10.1038/bjc.2015.388.
No abstract available

Publication types

  • Published Erratum